CDC: Dengue Fever Cases Expected to Rise in the United States This Summer
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
WEDNESDAY, June 26, 2024 -- On Tuesday, the U.S. Centers for Disease Control and Prevention issued a health advisory warning of a heightened risk of dengue fever infections in the United States.
"Dengue transmission peaks during the warmer and wetter months in many tropical and subtropical regions," the agency noted in its advisory. "Dengue cases are likely to increase as global temperatures increase."
In the United States, Puerto Rico has been hardest hit: Of 2,241 U.S. dengue cases reported this year, 1,498 occurred in that U.S. territory in the Caribbean. In March, a public health emergency was declared there after cases of the mosquito-borne illness broke historical records. For comparison, 3,036 dengue cases were reported in all of 2023 in the U.S. and its territories.
Still, America is not the only country grappling with the troubling spread of dengue fever. This year, the global incidence of dengue fever has been the highest on record, especially in Latin American countries, where nearly 9.4 million dengue cases have been reported. That is twice as many as in all of 2023.
The CDC alert recommends that health care providers be on the lookout for dengue, particularly among patients with fever who have recently traveled to places where it is an endemic disease. They are also advised to quickly report any dengue cases to public health authorities and promote mosquito bite prevention measures for their patients.
The agency added that it is also improving and expanding laboratory testing to diagnose cases more quickly and effectively, as well as educating the public on the disease and how to prevent it.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-27 03:15
Read more
- Just 5 Extra Minutes of Exercise Per Day Could Lower Blood Pressure
- American Society of Anesthesiologists, Oct. 18 to 22
- Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
- Neurogene Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
- Poll Finds Most Americans Stressed Over Election, Future of Nation
- First Cases of Sexually Transmitted Ringworm Reported in the U.S.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions